Sci Pharmtech (TPE:4119) Net Income (Continuing Operations) : NT$522 Mil (TTM As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Sci Pharmtech's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was NT$32 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$522 Mil.

Sci Pharmtech Net Income (Continuing Operations) Historical Data

The historical data trend for Sci Pharmtech's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Net Income (Continuing Operations) Chart

Sci Pharmtech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

360.12

55.70

308.78

294.72

534.68

Sci Pharmtech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial															44.51	62.19	381.15	46.83	31.74

Sci Pharmtech Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$522 Mil.

Sci Pharmtech (TPE:4119) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Sci Pharmtech Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sci Pharmtech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856

Website

https://www.sci-pharmtech.com.tw

Sci Pharmtech Inc is engaged in the research and development, manufacture, and sales of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, China, Switzerland, Spain, and others.

Sci Pharmtech Headlines

No Headlines